MedPath

A clinical trial to study the efficacy of Ilaguseena chooranam for Venpadai

Phase 2
Conditions
Health Condition 1: null- patients suffering from venpadaiHealth Condition 2: L80- Vitiligo
Registration Number
CTRI/2018/08/015453
Lead Sponsor
S karthika
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Hypo pigmented patches with hyper pigmented border without any structural changes in any part of the body. vitiligo present any part of the body.Patients who are willing to stay in IPD Ward for 27 days or willing to attend OPD. Children who are willing to undergo investigation and give blood and urine samples for laboratory investigation. Patientâ??s informant / Parent willing to sign the informed consent stating that he/she will consciously stick to the treatment during 27 days but can opt out of the trial of his / her own conscious discretion.

Exclusion Criteria

Albinism

Dermatological aspect of leprosy

Tinea versicolor

Burn scars

Dermatological aspect of addisons diseases

Post inflammatory hypopigmentation

Pityriasis alba

Alopecia aerate

chemical leucoderma

white patches on mucous membrane

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The Therapeutic Efficacy of Trial drug Ilaguseena Chooranam on Venpadai <br/ ><br>Timepoint: 27 days
Secondary Outcome Measures
NameTimeMethod
Evaluation of Siddha Diagnostic ParametersTimepoint: 27 days
© Copyright 2025. All Rights Reserved by MedPath